MedPath

Epinephrine

These highlights do not include all the information needed to use EPINEPHRINE INJECTION USP safely and effectively. See full prescribing information for EPINEPHRINE INJECTION USP. EPINEPHRINE INJECTION USP, for intravenous useInitial U.S. Approval: 1939

Approved
Approval ID

f2b5f15b-8541-466a-a27a-ee57bc4aac67

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2023

Manufacturers
FDA

International Medication Systems, Limited

DUNS: 055750020

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Epinephrine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76329-3318
Application NumberNDA211363
Product Classification
M
Marketing Category
C73594
G
Generic Name
Epinephrine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 31, 2023
FDA Product Classification

INGREDIENTS (9)

EPINEPHRINEActive
Quantity: 0.1 mg in 1 mL
Code: YKH834O4BH
Classification: ACTIB
SODIUM CITRATEInactive
Quantity: 1.5 mg in 1 mL
Code: 1Q73Q2JULR
Classification: IACT
SODIUM METABISULFITEInactive
Code: 4VON5FNS3C
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Quantity: 3.3 mg in 1 mL
Code: 2968PHW8QP
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.004 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 8.2 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
NITROGENInactive
Code: N762921K75
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Epinephrine - FDA Drug Approval Details